Bajaj HealthCare Limited (NSE:BAJAJHCARE)
India · Delayed Price · Currency is INR 325.35
+10.10 (3.20%)
Nov 11, 2026, 1:40 PM IST
Bajaj HealthCare Market Cap
Bajaj HealthCare has a market cap or net worth of 10.95 billion as of November 10, 2026. Its market cap has decreased by 20.51% in one year.
Market Cap
10.95B
Enterprise Value
13.63B
Revenue
6.56B
Global Rank
n/a
Country Rank
n/a
PE Ratio
51.65
ChartMarket Cap Chart
Since May 10, 2016, Bajaj HealthCare's market cap has increased from 1.16B to 10.95B, an increase of 846.01%. That is a compound annual growth rate of 23.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 10.95B | -16.50% |
| Dec 31, 2025 | 13.11B | -27.72% |
| Dec 31, 2024 | 18.14B | 74.95% |
| Dec 29, 2023 | 10.37B | -15.46% |
| Dec 30, 2022 | 12.27B | 7.73% |
| Dec 31, 2021 | 11.39B | 85.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 30.35B |
| Sakar Healthcare | 22.89B |
| Indoco Remedies | 20.25B |
| Windlas Biotech | 20.10B |
| Beta Drugs | 19.07B |
| Jagsonpal Pharmaceuticals | 14.36B |
| Anlon Healthcare | 14.31B |
| Bafna Pharmaceuticals | 11.18B |